AIM: The objective of this study was to develop and validate a brief tool, the Dual Diagnosis Screening Instrument (DDSI), to screen psychiatric disorders in substance users in treatment and nontreatment-seeking samples. METHODS: A total of 827 substance users (66.5% male, mean age 28.6±9.9 years) recruited in treatment (in- and outpatient) and nontreatment (substance user volunteers in university research studies) settings were assessed by trained interviewers using the DDSI and the Psychiatric Research Interview for Substance and Mental Disorders (PRISM) as the criterion standard. Both instruments were administered blind to the results of the other. Disorders obtained with the DDSI were compared to lifetime diagnoses obtained with the PRISM. Sensitivity, specificity, negative, and positive predictive values were estimated. Also test-retest reliability of the DDSI was assessed. RESULTS: The DDSI showed a high sensitivity (≥80%) for identifying lifetime depression, mania, psychosis, panic, social phobia, and specific phobia disorders. Specificity was ≥82% for those diagnoses. Test-retest κ showed excellent agreement (range 81-95%). The mean duration of the DDSI administration was 16.8±2.5 min. CONCLUSION: The DDSI is a valid and easy-to-administer screening tool to detect possible psychiatric comorbidity among substance users.
AIM: The objective of this study was to develop and validate a brief tool, the Dual Diagnosis Screening Instrument (DDSI), to screen psychiatric disorders in substance users in treatment and nontreatment-seeking samples. METHODS: A total of 827 substance users (66.5% male, mean age 28.6±9.9 years) recruited in treatment (in- and outpatient) and nontreatment (substance user volunteers in university research studies) settings were assessed by trained interviewers using the DDSI and the Psychiatric Research Interview for Substance and Mental Disorders (PRISM) as the criterion standard. Both instruments were administered blind to the results of the other. Disorders obtained with the DDSI were compared to lifetime diagnoses obtained with the PRISM. Sensitivity, specificity, negative, and positive predictive values were estimated. Also test-retest reliability of the DDSI was assessed. RESULTS: The DDSI showed a high sensitivity (≥80%) for identifying lifetime depression, mania, psychosis, panic, social phobia, and specific phobia disorders. Specificity was ≥82% for those diagnoses. Test-retest κ showed excellent agreement (range 81-95%). The mean duration of the DDSI administration was 16.8±2.5 min. CONCLUSION: The DDSI is a valid and easy-to-administer screening tool to detect possible psychiatric comorbidity among substance users.
Authors: Deborah S Hasin; Dvora Shmulewitz; Malka Stohl; Eliana Greenstein; Christina Aivadyan; Kara Morita; Tulshi Saha; Efrat Aharonovich; Jeesun Jung; Haitao Zhang; Edward V Nunes; Bridget F Grant Journal: Drug Alcohol Depend Date: 2015-04-06 Impact factor: 4.492
Authors: Deborah S Hasin; Eliana Greenstein; Christina Aivadyan; Malki Stohl; Efrat Aharonovich; Tulshi Saha; Rise Goldstein; Edward V Nunes; Jeesun Jung; Haitao Zhang; Bridget F Grant Journal: Drug Alcohol Depend Date: 2014-12-18 Impact factor: 4.492
Authors: Romain Icick; Ingrid Melle; Bruno Etain; Margrethe Collier Høegh; Sébastien Gard; Sofie R Aminoff; Marion Leboyer; Ole A Andreassen; Raoul Belzeaux; Chantal Henry; Thomas D Bjella; Jean-Pierre Kahn; Nils Eiel Steen; Frank Bellivier; Trine Vik Lagerberg Journal: Front Psychiatry Date: 2022-05-03 Impact factor: 5.435
Authors: Rosa Maza-Quiroga; Nuria García-Marchena; Pablo Romero-Sanchiz; Pedro Araos; Vicente Barrios; María Pedraz; Antonia Serrano; Raquel Nogueira-Arjona; Juan Jesus Ruiz; Maribel Soria; Rafael Campos; Julie Ann Chowen; Jesus Argente; Marta Torrens; Meritxell López-Gallardo; Eva María Marco; Fernando Rodríguez de Fonseca; Francisco Javier Pavón Journal: PeerJ Date: 2017-10-12 Impact factor: 2.984
Authors: Hanna Dauber; Barbara Braun; Tim Pfeiffer-Gerschel; Ludwig Kraus; Oliver Pogarell Journal: Int J Ment Health Addict Date: 2017-07-11 Impact factor: 3.836
Authors: Patrícia B de Abreu; Hugo Cogo-Moreira; Regina A Pose; Ronaldo Laranjeira; Raul Caetano; Carolina M Gaya; Clarice S Madruga Journal: Braz J Psychiatry Date: 2017-05-22 Impact factor: 2.697